Leylabadlo Hamed Ebrahimzadeh, Pourlak Tala, Bialvaei Abed Zahedi, Aghazadeh Mohammad, Asgharzadeh Mohammad, Kafil Hossein Samadi
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Infectious Disease and Tropical Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Afr J Infect Dis. 2017 Jun 8;11(2):39-53. doi: 10.21010/ajid.v11i2.6. eCollection 2017.
The emergence and spread of extended spectrum β-lactamase (ESBL)-producing Gram- negative bacteria (GNB), particularly in Enterobacteriaceae, , and , have increased all over the world. ESBLs are characterized by their ability to hydrolyze β-lactams, early cephalosporins, oxyimino-thiazolyl cephalosporins, and monobactams, but not cephamycins or carbapenems. The rate of nosocomial infections caused by ESBL-producing GNB in Asia Pacific has increased and several studies have identified their prevalence in the region. The aim of this study is to review the prevalence of ESBL-producing GNB in the West Asia and the Middle East with a particular focus on Iran.
The available evidence from various studies (Microbia and clinical studies, retrieved from the PubMed, and Scopus databases) regarding the ESBL producing Gram negative bacteria in Iran were evaluated.
In almost all parts of the country, high resistance has been observed, especially in the central part of Iran. Up to 89.8% , 72.1% , 84.2% , and 83.8% isolates are ESBL positive.
The present study showed the increasing prevalence of ESBLs in different regions of Iran, which could be useful to strategic policy towards reducing reduce their prevalence.
产超广谱β-内酰胺酶(ESBL)的革兰氏阴性菌(GNB),尤其是肠杆菌科细菌的出现和传播在全球范围内有所增加。ESBL的特点是能够水解β-内酰胺类、早期头孢菌素、氧亚氨基噻唑基头孢菌素和单环β-内酰胺类,但不能水解头霉素或碳青霉烯类。亚太地区由产ESBL的GNB引起的医院感染率有所上升,多项研究已确定了该地区此类细菌的流行情况。本研究的目的是回顾西亚和中东地区产ESBL的GNB的流行情况,特别关注伊朗。
评估了从PubMed和Scopus数据库检索到的关于伊朗产ESBL革兰氏阴性菌的各种研究(微生物学和临床研究)中的现有证据。
在该国几乎所有地区都观察到了高耐药性,尤其是在伊朗中部地区。高达89.8%的[具体细菌名称1]、72.1%的[具体细菌名称2]、84.2%的[具体细菌名称3]和83.8%的[具体细菌名称4]分离株为ESBL阳性。
本研究表明ESBL在伊朗不同地区的流行率不断上升,这可能有助于制定降低其流行率的战略政策。